Christopher Bonnet is a Cardiology physician affiliated with Allegheny Health Network. OpenAlex indexes 42 publications with 520 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
320 E North Ave
Agh Electrophysiology
Pittsburgh, PA 152124756
Telephone
412-359-6444Registry record last updated 17 Nov 2016.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20251 payment
- Abbott LaboratoriesProgram year20251 payment
- ABIOMEDProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
53.7%Factor Xa inhibitor53.7%Eliquis87%Xarelto13%Part D<11 patientsCardiovascular
46.3%Beta blocker18.4%Sotalol49%Metoprolol Tartrate28%Metoprolol Succinate23%Part D<11 patientsAntiarrhythmic15.3%Flecainide Acetate59%Amiodarone Hcl41%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Where do we go from here? Beyond the MagnaSafe trial: A focus beyond a ‘safety-first’ notion. An MRI study in 500 consecutive patients
International Journal of Cardiology
2021 - SAFETY OR EFFICACY; CAN OR SHOULD WE HAVE BOTH? TABOO DEVICES IN THE MRI ENVIRONMENT
Journal of the American College of Cardiology
2021 - MRI EFFECTS ON PACEMAKER/ICD STABILITY: SHOULD WE BE CONCERNED ANY LONGER? AN IN VIVO STUDY
Journal of the American College of Cardiology
2020 - 1000 CONSECUTIVE PATIENTS EVALUATED FOR SAFETY AND EFFICACY: A FOCUSED STUDY OF PROHIBITED DEVICES IN THE MRI ENVIRONMENT
Journal of the American College of Cardiology
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Susan Manzi, MD
Allegheny Health Network
Sushil Beriwal, MD
Allegheny Health Network
Srinivas Murali, MD
Allegheny Health Network
Hiran Fernando, MD
Allegheny Health Network
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”